Galapagos | Rörelsekostnader



Operating Expenses Ändra Datum
argenx SE USD 635.37M 62.66M 2024-12
AstraZeneca USD 12.86B 2.06B 2024-12
Biogen USD 2.01B 13.3M 2024-12
Genmab DKK 4.25B 812M 2024-12
Gilead Sciences USD 4.43B 687M 2025-03
GlaxoSmithKline GBP 7.42B 402M 2024-12
GRIFOLS EUR 1.6B 128.03M 2024-12
Hikma Pharmaceutical USD 1.24B 87M 2024-06
Incyte USD 877.18M 114.6M 2024-12
Merck EUR 4.22B 52M 2024-12
Neurocrine Biosciences USD 485.7M 47.4M 2024-12
Novartis USD 11.28B 1.73B 2024-12
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 8.32B 1.55B 2025-03
UCB EUR 1.23B 1.31B 2024-06
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12



Galapagos Rörelsekostnader - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Apr 2025.